Buy Mirna Therapeutics Stock | MIRN Stock Price & Latest News | Public
MIRN

Mirna Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About MIRN

    Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also work...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.31
    -0.46
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.38

    Actual EPS
    Q4 2020

    Stats

    Market Cap$87,08M
    Volume73,8k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$3.99
    1 Year Low$1.35
    Open$2.61
    High$2.61
    Low$2.34

    Buy any stock with any amount of money.

    Download the App
    Download the app